Chapel Hill public company could be looking for a buyer soon


Short on cash and facing a potential delisting, a Chapel Hill medical technology company could look toward a sale or merger.

Previous Rockville's RegenxBio lays out potential path to market for its first gene therapy treatments
Next Highmark Health finishes Q3 with $19.5B in revenue, operating gains of $594M